Hiltrud Brauch completed her PhD at the University of Heidelberg, Germany, and postdoctoral studies as a Fogarty International Visiting Fellow at the National Institutes of Health (NIH), National Cancer Institute (NCI), Frederick, Maryland, USA. She works on the elucidation of breast cancer susceptibility genes with a strong focus on breast cancer pharmacogenomics and mechanistic approaches towards overcoming endocrine resistance. During her scientific career, she has held positions with increasing responsibilities currently being the deputy director of the Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology in Stuttgart, a non-profit private research institute of the Robert Bosch Foundation. She has published more than 250 papers in reputed scientific journals and is an Associate Professor at the University of Tübingen, Germany.